Product NDC: | 49884-210 |
Proprietary Name: | Propafenone Hydrochloride |
Non Proprietary Name: | propafenone hydrochloride |
Active Ingredient(s): | 325 mg/1 & nbsp; propafenone hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-210 |
Labeler Name: | Par Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078540 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110103 |
Package NDC: | 49884-210-10 |
Package Description: | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-210-10) |
NDC Code | 49884-210-10 |
Proprietary Name | Propafenone Hydrochloride |
Package Description | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49884-210-10) |
Product NDC | 49884-210 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | propafenone hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110103 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical, Inc. |
Substance Name | PROPAFENONE HYDROCHLORIDE |
Strength Number | 325 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiarrhythmic [EPC] |